Eucodis Bioscience, INVISTA to develop bio-derived processes for production of industrial chemicals

INVISTA and Eucodis Bioscience, an Austrian biotechnology company with strong expertise in enzyme engineering and industrial enzyme development, announce a collaboration for the screening and engineering of enzymes to further develop bio-derived processes for the production of industrial chemicals.

The collaboration will leverage INVISTA's capabilities in biotechnology and catalysis, its knowledge of the chemicals industry, and Eucodis' enzyme discovery and engineering capabilities to assist in the development of new, bio-derived routes to industrial chemicals.

"Eucodis Bioscience has a proven track record in enzyme engineering by applying its leading-edge technologies," said Karl Hübler, CEO of Eucodis Bioscience. "We are very excited to provide these services to an innovative, globe-leading company like INVISTA to create tailor-made enzyme solutions for manufacturing industrial chemicals and polymers."

Warren Primeaux, president of INVISTA Intermediates, said, "We see Eucodis' capabilities as very complementary to our own and are pleased to announce this collaboration, which aims to accelerate INVISTA's progress on a number of biotechnology initiatives."

INVISTA believes biotechnology has the potential to significantly improve the cost and availability of several chemicals and raw materials that are used to produce its current products.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study finds skincare products could expose children to harmful phthalates